William Meyers

Long only, tech, biotech, research analyst
William Meyers
Long only, tech, biotech, research analyst
Contributor since: 2011
12/18/14
William Meyers
Alexion's Rare Disease Model Analyzed $ALXN http://seekingalpha.com/a/1nath
12/11/14
William Meyers
Agenus: Herpes Competition And Cancer Checkpoint Prospects $AGEN http://seekingalpha.com/a/1mx9z
12/3/14
William Meyers
Intel: Expiring Or Renewing With Mobile And Cloud? $INTC http://seekingalpha.com/a/1mhcn
12/1/14
William Meyers
Celgene Stock Price: Is It Bubbly? $CELG http://seekingalpha.com/a/1mc7x
11/19/14
William Meyers
Biogen Idec, PML Deaths, And Hemophilia Therapies $BIIB http://seekingalpha.com/a/1ls7n
11/4/14
William Meyers
Intuitive Surgical Staple Problem And Other Cautions $ISRG http://seekingalpha.com/a/1khfh
10/28/14
William Meyers
Seagate Grows Revenue, Raises Dividend $STX http://seekingalpha.com/a/1ju4v
10/22/14
William Meyers
Illumina Sequences Profits, Exceeding Q3 Guidance $ILMN http://seekingalpha.com/a/1jcdf
10/21/14
William Meyers
AMD Seasonality Does Not Imply Failure $AMD http://seekingalpha.com/a/1j9lf
10/19/14
William Meyers
Xilinx EPS Grows 27%, But What About The Future? $XLNX http://seekingalpha.com/a/1j59l
9/18/14
William Meyers
Dot Hill Nears Inflection Point $HILL http://seekingalpha.com/a/1hnut
9/17/14
William Meyers
Could GlaxoSmithKline Be A Better Investment Than Gilead? $GSK http://seekingalpha.com/a/1hm41
8/27/14
William Meyers
Mylan: Deeply Undervalued On Unwarranted Approval Concerns $MYL http://seekingalpha.com/a/1gm3x
8/15/14
William Meyers
Will Inovio's Deal With Roche Lead To A Cancer Blockbuster? $INO http://seekingalpha.com/a/1g0rl
8/7/14
William Meyers
Vertex's Price And Prospects Compared To Alexion $VRTX http://seekingalpha.com/a/1fbsz
8/5/14
William Meyers
How Microchip Ramped Earnings With 8-Bit Devices $MCHP http://seekingalpha.com/a/1f1tj
7/29/14
William Meyers
Can Biogen Idec Take Wing With Tecfidera? $BIIB http://seekingalpha.com/a/1eg81
7/23/14
William Meyers
Is Inovio Undervalued After Positive HPV Therapy Results? $INO http://seekingalpha.com/a/1e1gd
7/23/14
good article thanks
7/1/14
William Meyers
3 More Reasons To Stay Long AMD $AMD http://seekingalpha.com/a/1d7c7
6/9/14
William Meyers
Gilead Down On Merck Idenix Deal, But Little To Fear $GILD http://seekingalpha.com/a/1cfgt
6/5/14
William Meyers
Seagate Adds Potential Value With SSD Capabilities $STX http://seekingalpha.com/a/1cay1
5/13/14
William Meyers
Agenus Platforms Provide Many Shots On Commercialization Goal $AGEN http://seekingalpha.com/a/1bhoz
4/29/14
William Meyers
Celgene In 2015: $200 Per Share $CELG http://seekingalpha.com/a/1aken
4/9/14
William Meyers
Regeneron Down 15% From 52-Week High: Buy? $REGN http://seekingalpha.com/a/19q75
3/25/14
William Meyers
Dendreon Ready For A Rebound $DNDN http://seekingalpha.com/a/196rp
2/18/14
William Meyers
Diverging Strategies Make AMD, Intel And Nvidia All Buys http://seekingalpha.com/a/17hpb
2/5/14
William Meyers
Xilinx Has A Brighter Future Than Intel $XLNX http://seekingalpha.com/a/16r4x
1/14/14
William Meyers
Celgene In 2017: $375 Per Share $CELG http://seekingalpha.com/p/1j6wd
1/9/14
William Meyers
Akamai Q4 Could Be A Catalyst $AKAM http://seekingalpha.com/a/15iyd
1/6/14
William Meyers
Marvell Technologies Will Ramp Smartphone Chip Profits In 2014 $MRVL http://seekingalpha.com/a/15dlb